Company intelligence / Profile preview

Alomone Labs

Jerusalem, Jerusalem District, Israelalomone.com ↗

Ownership: Private
Employees: ~37
Development stage: Commercial

Overview

Alomone Labs does not develop therapeutics but supplies validated reagents—antibodies and pharmacological tools—for membrane protein research. Their products are widely used in academic and industry labs globally. No clinical results as they do not run clinical programs.

Therapeutic areas: CardiovascularNeurology
Modalities: AntibodySmall moleculeProteinPeptidesRecombinant proteinPeptide toxin (venom-derived)Growth factor (Neurotrophin)
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Alomone Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alomone Labs.

Explore the full profile